The expression of survivin and its related genes in adipocyte-derived stem cell by demethylation

Korean Journal of Anesthesiology

Volumn 58, Issue 4, 2010, Pages 383-390

  Yoon, Kwang ^a   Lim, Young Soo ^a   Yu, Soo Bong ^a   Kim, Doo Sik ^a   Ryu, Sie Jeong ^a   Kim, Kyung Han ^a   Jang, Tae Ho ^a   Kim, Se Hwan ^a  

^a Kosin University   (South Korea)

Author keywords

Adult stem cell; c Myc; ERK; MEK; p53; Survivin

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; MYC PROTEIN; PROTEIN P53; SURVIVIN;

ADIPOCYTE; ADIPOCYTE DERIVED STEM CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL POPULATION; CELL STRUCTURE; CONTROLLED STUDY; DEMETHYLATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEM CELL; WESTERN BLOTTING;

EID: 77953376276     PISSN: 20056419     EISSN: 20057563     Source Type: Journal    
DOI: 10.4097/kjae.2010.58.4.383     Document Type: Article

References (26)

1. Altieri DC. New wirings in the survivin networks. Oncogene 2008; 27: 6276-6284
2. Andersen MH, thor SP. Survivin-a universal tumor antigen. Histol Histopathol 2002; 17: 669-675
3. Zangemeister Wittke U, Simon HU. An IAP in action: the multiple roles of survivin in differentiation, immunity and malignancy. Cell Cycle 2004; 3: 1121-1123
4. Watson AJ. An overview of apoptosis and the prevention of colorectal cancer. Crit Rev Oncol Hematol 2006; 57: 107-121 (Pubitemid 43139699)
5. Cosgrave N, Hill AD, Young LS. Growth factor-dependent regulation of survivin by c-myc in human breast cancer. J Mol Endocrinol 2006; 37: 377-390 (Pubitemid 46085164)
6. McCubrey JA, Steelman LS, Franklin RA, Abrams SL, Chappell WH, Wong EW, et al. Targeting the RAF/MEK/ERK, PI3K/AKT and P53 pathways in hematopoietic drug resistance. Adv Enzyme Regul 2007; 47: 64-103.
7. Arango D, Mariadason JM, Wilson AJ, Yang W, Corner GA, Nichololas C, et al. c-Myc overexpression sensitises colon cancer cells to camptothecin-induced apoptosis. Br J Cancer 2003; 89: 1757-1765 (Pubitemid 37464151)
8. Nabilsi NH, Broaddus RR, Loose DS. DNA methylation inhibits p53-mediated survivin repression. Oncogene 2009; 28: 2046-2050
9. Wang JC, Dick JE. Cancer stem cells: lessons from leukemia. Trends Cell Biol 2005; 15: 494-501. (Pubitemid 41253469)
10. Seoane J, Le HV, Massague J. Myc suppression of p21 Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 2002; 419: 729-734 (Pubitemid 35177959)
11. Bapat SA, Mali AM, Koppikar CB. Kurrry NK. Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer. Cancer Res 2005; 65: 3025-3029
12. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7: 211-228 (Pubitemid 32295155)
13. Brzoska M, Geiger H, Gauer S, Baer P. Epithelial differentiation of human adipose tissue-derived adult stem cells. Biochem Biophys Res Commun 2005; 330: 142-150 (Pubitemid 40394946)
14. Hoffman WH, Biade S, Zilfou JT, Chen J, Murphy M. Transcriptional repression of the antiapoptotic survivin gene by wild type p53. J Biol Chem 2002; 277: 3247-3257 (Pubitemid 34953189)
15. Sommer KW, Schamberger CJ, Schmidt GE, Sasgary S, Cerni C. Inhibitor of apoptosis protein (IAP) survivin is upregulated by oncogenic c-H-Ras. Oncogene 2003; 22: 4266-4280 (Pubitemid 36876247)
16. Calabrese P, Tavare S, Shibata D. Pretumor progression: clonal evolution of human stem cell populations. Am J Pathol 2004; 164: 1337-1346 (Pubitemid 38387799)
17. Costa FF, Le Blanc K. Brodin B. Concise review: cancer/testis antigen, stem cells, and cancer. Stem Cells 2007; 25: 707-711 (Pubitemid 46354230)
18. Fukuda S, Pelus LM. Survivin, a cancer target with an emerging role in normal adult tissues. Mol Cancer Ther 2006; 5: 1087-1098 (Pubitemid 43881300)
19. Fukuda S, Pelus LM. Elevation of survivin levels by hematopoietic growth factors occurs in quiescent CD34+ hematopoietic stem and progenitor cells before cell cycle entry. Cell Cycle 2002; 1: 322-326
20. Wachsman JT. DNA methylation and the association between genetic and epigenetic changes: relation to carcinogenesis. Mutat Res 1997; 375: 1-8. (Pubitemid 27152196)
21. Simonsson S, Gurdon J. DNA demethylation is necessary for the epigenetic reprogramming of somatic cell nuclei. Nat Cell Biol 2004; 6: 984-990 (Pubitemid 39359851)
22. Momparler RL, Bovenzi V. DNA methylation and cancer. J Cell Physiol 2000; 183: 145-154
23. Hattori M, Sakamoto H, Satoh K, Yamamoto T. DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes. Cancer Lett 2001; 169: 155-164 (Pubitemid 32595563)
24. Carter BZ, Milella M, Altieri DC, Andreeff M. Cytokine-regulated expression of survivin in myeloid leukemia. Blood 2001; 97: 2784-2790
25. Yuan J, Yang BM, Zhong ZH, Shats I, Milyavsky M, Rotter V, et al. Upregulation of survivin during immortalization of nontransformed human fibroblasts transduced with telomerase reverse transcriptase. Oncogene 2009; 28: 2678-2689
26. Filion TM, Qiao M, Ghule PN, Mandeville M, van Wijnen AJ, Stein JL, et al. Survival responses of human embryonic stem cells to DNA damage. J Cell Physiol 2009; 220: 586-592